India, Aug. 7 -- Eli Lilly and Company (LLY) fell 13.40 percent to $646.35 on Thursday after releasing disappointing second-quarter results.
Revenue dropped to 3.82 billion euros, while total comprehensive loss widened to 12.86 billion euros from 2.61 billion euros a year ago.
The stock opened at $675.66 and traded between $633.20 and $678.29, with volume spiking to 22.7 million shares compared to an average of 3.7 million on the New York Stock Exchange. Shares hit a new 52-week low during the session, down sharply from the year's high of $972.53.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....